Development and Characterization of Core Shell Nanoparticle for Enhanced Drug Delivery to Treat Solid Tumor: Preparation and In-Vitro Assessment

  • Nishi Mody Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M.P., 470003 India
  • Rajeev Sharma Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M.P., 470003 India
  • Varun Kushwah Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India
  • Sanyog Jain Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India
  • Suresh P. Vyas Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India

Abstract

Mortalities from cancer in the world are projected to continue rising, with an estimated 9 million and 11.4 million people dying from cancer in 2015 and 2030, respectively. Rates are rising as more people live to an old age and as mass lifestyle changes occur in the developing world. With present treating regimen for cancer, dose-limited toxicity is a big reason that reduces the efficacy of cancer treatments. In search for more effective cancer treatments, nanosized drug delivery systems, those are capable of delivering their drug payload selectively to cancer cells such as nanoparticles, solid lipid nanoparticles, liposomes are among the most promising approaches. Core shell nanoparticles are one of the investigated moieties in recent years that are seeking much attention nowadays for biomedical applications including the field of oncology.The present work aims at developing a core shell nanoparticle comprising Poly (D, L –lactide –co –glycolide) (PLGA) core and polyethyleneimine (PEI) shell loaded with anticancer bioactive docetaxel (DTX) for passive targeting of the tumor tissue. It is expected that incorporation of PEI will improve the uptake and subsequent release of the drug in the cytosol due to endosomal escape phenomenon.


Keywords: Solid tumor; nanotechnology; nanoparticle; PLGA

Downloads

Download data is not yet available.

Author Biographies

Nishi Mody, Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M.P., 470003 India

Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M.P., 470003 India

Rajeev Sharma, Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M.P., 470003 India

Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M.P., 470003 India

Varun Kushwah, Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India

Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India

Sanyog Jain, Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India

Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India

Suresh P. Vyas, Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India

Department of Pharmaceutics, Centre for Pharmaceutical Nanotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India

References

1. Jain A, Jain SK. Stimuli-responsive Smart Liposomes in Cancer Targeting. Curr Drug Targets. 2018; 19(3):259-70. doi:10.2174/1389450117666160208144143.
2. Bazak R, Houri M, El Achy S, Hussein W, Refaat T. Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Molecular and clinical oncology. 2014; 2(6):904-8.
3. Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Cancer Nanotechnology. Springer; 2010. p. 25-37.
4. Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proceedings of the Japan Academy, Series B. 2012; 88(3):53-71.
5. Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X et al. Lectin-conjugated PEG–PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials. 2006; 27(18):3482-90.
6. Song C, Noh Y-W, Lim YT. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response. International journal of nanomedicine. 2016; 11:3753.
7. Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 1978; 90(2):809-15.
8. Gupta M, Chashoo G, Sharma PR, Saxena AK, Gupta PN, Agrawal GP et al. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Molecular pharmaceutics. 2014; 11(3):697-715.
9. Katiyar SS, Kushwah V, Dora CP, Jain S. Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate. International journal of pharmaceutics. 2019; 557:86-96.
10. Moosavian SA, Abnous K, Badiee A, Jaafari MR. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Colloids Surf B Biointerfaces. 2016; 139:228-36.
11. Pillai JJ, Thulasidasan AKT, Anto RJ, Devika NC, Ashwanikumar N, Kumar GV. Curcumin entrapped folic acid conjugated PLGA–PEG nanoparticles exhibit enhanced anticancer activity by site specific delivery. RSC Advances. 2015; 5(32):25518-24.
12. Yamashita S, Katsumi H, Hibino N, Isobe Y, Yagi Y, Tanaka Y et al. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis. Biomaterials. 2018; 154:74-85.
13. Shirakura T, Ray A, Kopelman R. Polyethylenimine incorporation into hydrogel nanomatrices for enhancing nanoparticle-assisted chemotherapy. RSC Advances. 2016; 6(53):48016-24.
Statistics
146 Views | 145 Downloads
How to Cite
1.
Mody N, Sharma R, Kushwah V, Jain S, Vyas SP. Development and Characterization of Core Shell Nanoparticle for Enhanced Drug Delivery to Treat Solid Tumor: Preparation and In-Vitro Assessment. JDDT [Internet]. 24Apr.2019 [cited 24Oct.2020];9(2-A):14-9. Available from: http://jddtonline.info/index.php/jddt/article/view/2764